Carvajal RD - Search Results

1

Tebentafusp in advanced uveal melanoma: proof of principle for the efficacy of T-cell receptor therapeutics and bispecifics in solid tumors.

Liu AW, Wei AZ, Maniar AB, Carvajal RD. Liu AW, et al. Among authors: carvajal rd. Expert Opin Biol Ther. 2022 Aug;22(8):997-1004. doi: 10.1080/14712598.2022.2031970. Epub 2022 Feb 2. Expert Opin Biol Ther. 2022. PMID: 35060440 Review.

2

Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).

Carvajal RD, Schwartz GK, Mann H, Smith I, Nathan PD. Carvajal RD, et al. BMC Cancer. 2015 Jun 10;15:467. doi: 10.1186/s12885-015-1470-z. BMC Cancer. 2015. PMID: 26059332 Free PMC article. Clinical Trial.

3

Treatment of Uveal Melanoma.

Shoushtari AN, Carvajal RD. Shoushtari AN, et al. Among authors: carvajal rd. Cancer Treat Res. 2016;167:281-93. doi: 10.1007/978-3-319-22539-5_12. Cancer Treat Res. 2016. PMID: 26601868 Review.

4

A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma.

Shoushtari AN, Ong LT, Schoder H, Singh-Kandah S, Abbate KT, Postow MA, Callahan MK, Wolchok J, Chapman PB, Panageas KS, Schwartz GK, Carvajal RD. Shoushtari AN, et al. Among authors: carvajal rd. Melanoma Res. 2016 Jun;26(3):272-7. doi: 10.1097/CMR.0000000000000234. Melanoma Res. 2016. PMID: 26795274 Free PMC article. Clinical Trial.

5

Selumetinib for the treatment of metastatic uveal melanoma: past and future perspectives.

Komatsubara KM, Manson DK, Carvajal RD. Komatsubara KM, et al. Among authors: carvajal rd. Future Oncol. 2016 Jun;12(11):1331-44. doi: 10.2217/fon-2015-0075. Epub 2016 Apr 5. Future Oncol. 2016. PMID: 27044592 Review.

6

Metastatic disease from uveal melanoma: treatment options and future prospects.

Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Carvajal RD, et al. Br J Ophthalmol. 2017 Jan;101(1):38-44. doi: 10.1136/bjophthalmol-2016-309034. Epub 2016 Aug 29. Br J Ophthalmol. 2017. PMID: 27574175 Free PMC article. Review.

7

The promise and pitfalls of the many methods of plasma genotyping.

Komatsubara KM, Carvajal RD, Sacher AG. Komatsubara KM, et al. Among authors: carvajal rd. Expert Opin Biol Ther. 2016 Nov;16(11):1313-1316. doi: 10.1080/14712598.2016.1229769. Epub 2016 Sep 12. Expert Opin Biol Ther. 2016. PMID: 27608417 No abstract available.

8

Update on the treatment of uveal melanoma.

Carvajal RD. Carvajal RD. Clin Adv Hematol Oncol. 2016 Oct;14(10):768-770. Clin Adv Hematol Oncol. 2016. PMID: 27930627 No abstract available.

9

Adopting a new stance on immunotherapy for uveal melanoma.

Komatsubara KM, Carvajal RD. Komatsubara KM, et al. Among authors: carvajal rd. Lancet Oncol. 2017 Jun;18(6):702-704. doi: 10.1016/S1470-2045(17)30254-1. Epub 2017 Apr 7. Lancet Oncol. 2017. PMID: 28395881 No abstract available.

10

Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.

Komatsubara KM, Carvajal RD. Komatsubara KM, et al. Among authors: carvajal rd. Curr Oncol Rep. 2017 Jul;19(7):45. doi: 10.1007/s11912-017-0606-5. Curr Oncol Rep. 2017. PMID: 28508938 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page